Swiss National Bank’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.77M Buy
351,900
+6,900
+2% +$53.3K ﹤0.01% 1596
2026
Q1
$2.2M Hold
345,000
﹤0.01% 1801
2025
Q4
$2.43M Buy
345,000
+81,200
+31% +$490K ﹤0.01% 1778
2025
Q3
$1.45M Buy
263,800
+6,700
+3% +$32.8K ﹤0.01% 1998
2025
Q2
$1.33M Sell
257,100
-4,300
-2% -$25.8K ﹤0.01% 2004
2025
Q1
$1.74M Hold
261,400
﹤0.01% 1852
2024
Q4
$1.93M Hold
261,400
﹤0.01% 1877
2024
Q3
$1.83M Buy
261,400
+36,700
+16% +$221K ﹤0.01% 1919
2024
Q2
$1.1M Buy
224,700
+37,900
+20% +$229K ﹤0.01% 2130
2024
Q1
$1.15M Buy
186,800
+37,800
+25% +$255K ﹤0.01% 2144
2023
Q4
$1.17M Sell
149,000
-16,600
-10% -$107K ﹤0.01% 2151
2023
Q3
$1.14M Buy
165,600
+1,700
+1% +$13.8K ﹤0.01% 2168
2023
Q2
$1.5M Buy
+163,900
New +$1.36M ﹤0.01% 2074

Other funds holding LFST

Swiss National Bank's LFST Position: Q2 2026 in Review

Swiss National Bank increased its Lifestance Health (LFST) stake by 2% in Q2 2026, buying an estimated $53.3K and bringing the position to 351,900 shares worth $3.77M. The position accounts for ﹤0.01% of the portfolio, ranked #1596.

Swiss National Bank first reported a position in LFST in Q2 2023 and has held it in 13 quarters since. 191 funds tracked by Wall St. Rank hold LFST as of Q2 2026.

  • Swiss National Bank held 351,900 shares of Lifestance Health worth $3.77M as of Q2 2026.
  • Swiss National Bank bought 6,900 Lifestance Health shares in Q2 2026, an estimated $53.3K.
  • Lifestance Health made up ﹤0.01% of Swiss National Bank's portfolio in Q2 2026, its #1596 holding.
  • Swiss National Bank first reported a position in Lifestance Health in Q2 2023 and has held it in 13 quarters since.
  • 191 funds tracked by Wall St. Rank held Lifestance Health as of Q2 2026.

Based on Swiss National Bank's 13F filing for Q2 2026, filed 11 Aug 2026.